Abstract 3552: Personalized neoantigen cancer vaccine assembled on DC targeting antibody improves cancer immunity
Year: 2022
Type: conference-abstract
Source: Cancer Research
Institutions: BrightPath Biotherapeutics (Japan), Teikyo University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4282944012
